Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05573230
PHASE1

A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants

Sponsor: Eli Lilly and Company

View on ClinicalTrials.gov

Summary

The main purpose of this study is to determine the levels of study drug called LY3502970 in the blood stream when administered alone and in combination with cyclosporine in healthy participants. The study will also evaluate the safety and tolerability of LY3502970 in healthy participants. This study will last up to approximately 76 days for each participant.

Official title: A Phase 1, Open-Label, Drug Interaction Study to Investigate the Effect of Multiple Doses of Cyclosporine on the Pharmacokinetics of LY3502970 in Healthy Participants

Key Details

Gender

All

Age Range

21 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2022-10-17

Completion Date

2023-01-17

Last Updated

2026-05-26

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Midazolam

Administered orally.

DRUG

LY3502970

Administered orally.

DRUG

Cyclosporine

Administered orally.

Locations (1)

Lilly Centre for Clinical Pharmacology

Singapore, Singapore